Professor David A V Morton

David is Professor of Engineering (Hon) at Deakin University, co-founder of Envirohale ltd and has worked extensively as a scientific consultant. David has worked in both industrial and academic roles, with experiences including:
• PhD in structural chemistry from University of Bristol.
• 1990 Senior Scientist at AEA Technology: R&D in aerosol containment and aerosol synthesis.
• 1997 Via Bath University CDFS and CDD Ltd, was a founding member of Vectura Group plc. As Head of Inhalation R&D, significant lead contributions included PowderHale® technology, formulation additives such as magnesium stearate and leucine, and inhaled glycopyrrolate.
• 2007 Emigrated to an academic role with Monash University: Established the Industrialization & Innovation Centre with GSK Australia (Best Australian research partnership), and co-inventor of the Monash Inhaled Oxytocin (2013 Australian Innovation of the Year).
• 2018 Deakin University: Director of Work Integrated Learning (WIL)- designed core WIL initiatives to enhance engineering student professional skill development in bespoke industrial placements.

Through experiences, David appreciates the importance of encouraging curiosity, fresh critical thinking, versatility and translating new patient-centered responses to unmet needs in the medical aerosol sector. He sees the DDL community as invaluable enablers of these and has been an enthusiastic supporter of the Aerosol Society and DDL since 1990 through multiple roles. Elected to the committee in 1992, he has contributed leadership including as General Secretary and through being the link between the Aerosol Society and DDL committees over significant periods of their evolution.
David is an author on over 40 distinct patent families yielding over 250 granted patents largely across pharmaceutical aerosol applications while also has a current publication h-index of 46.